NCH recently used the FDA-approved FlowTriever device to quickly and effectively remove two life-threatening blood clots from a patient’s pulmonary artery, preventing a potentially fatal pulmonary embolism. The procedure, which took less than 30 minutes, offers a game-changing approach to treating such clots, which can be fatal and often lead to significant blood loss during removal. Read More >
WINK News covers NCH’s use of the FlowTriever manufactured by Inari.
